Millie Heuer

Associate
Full contact info

Admissions and credentials

Washington

District of Columbia

Experience

Archon Biosciences Announces $20 Million Seed Financing

October 30, 2024

Cooley advised Archon Biosciences, a biotechnology company pioneering computationally designed antibody cages (AbCs) to unlock powerful therapeutic targets beyond the reach of existing modalities, on its $20 million seed financing led by Madrona Ventures.

Read more

Related contacts

Colleen Badgley
Partner, Seattle
Alan W. Tamarelli
Partner, New York
Willy Cowles
Associate, Seattle
Lucy Bauer
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle
John Sellers
Partner, Palo Alto
Timothy Shapiro
Partner, Palo Alto
Dr. Carol Laherty
Partner, Seattle
Millie Heuer
Associate, Seattle

Related Practices & Industries

Outpace Bio Announces $144 Million Oversubscribed Series B

August 1, 2024

Cooley advised Outpace Bio, a cell therapy company using unrivaled artificial intelligence-powered protein design to program immune cells for improved function inside patients battling solid tumors, on its $144 million oversubscribed Series B financing.

Read more

Related contacts

Colleen Badgley
Partner, Seattle
Sonya Erickson
Partner and Business Department Chair, Seattle
Christopher Kimball
Partner, Washington, DC
Mika Reiner Mayer
Partner, Palo Alto
John Sellers
Partner, Palo Alto
Timothy Shapiro
Partner, Palo Alto
Dillon Martinson
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Lucy Bauer
Associate, Seattle
Karen Gustavson
Associate, Seattle
Millie Heuer
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries